Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 8.9M | 4.9M | 23.9M | 3.2M |
Operating income | -10.0M | -5.0M | -23.9M | -3.3M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 807K | 782K | 880K | 907K |
Other income expense | — | — | — | — |
Pretax income | -4.4M | 4.7M | 910K | 6.8M |
Tax provision | -2.4M | -2.9M | -1.8M | 9.1M |
Net income | -2.0M | 7.6M | 2.7M | -2.4M |
Basic EPS | — | 0.0 | 0.0 | 0.0 |
Diluted EPS | — | 0.0 | 0.0 | -1 |
Basic average shares | — | 253.6M | 273.5M | 239.6M |
Diluted average shares | — | 253.6M | 273.5M | 239.6M |
EBITDA | -3.6M | 5.5M | 1.8M | 7.7M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |